Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Clinical trial NCT03191864 · COMPLETED
Trial details
- NCT number
- NCT03191864
- Sponsor
- Adare Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-22
- Primary completion
- 2019-01-03
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.